DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lu G, Kotha J, Cardenas JM. et al.
Abstract 18218: In vitro characterization of andexanet alfa (PRT064445), a specific fXa Inhibitor antidote versus aripazine (PER977), a non-specific reversal agent.
Circulation 2018;130(02):
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.